ESC 365 - Professor John Cleland

Speaker illustration

Professor John Cleland

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

Member of:

Heart Failure Association

Professor Cleland is a Cardiologist and Director of the Robertson Centre for Biostatistics (Glasgow), an internationally renowned Clinical Trials Unit offering a complete service both to academia and industry for cardiovascular and metabolic disease. His main interest is heart failure, extending from epidemiology & prevention, to Phase II-IV trials and guidelines. Particular current interests include myocardial substrate, congestion & inflammation, telemonitoring & theranostics. He qualified from the University of Glasgow in 1977, completed training at St. Mary's & Hammersmith Hospitals (London) and was awarded a Senior Fellowship by the British Heart Foundation. He was appointed Prof. at the University of Hull and, in 2013, the National Heart & Lung Institute, Royal Brompton & Harefield Hospitals, Imperial College London. He founded the European Journal of Heart Failure. He is Past-Chair of the ESC Working Group on heart failure and British Society for Heart Failure

Sessions Presentations Events Articles Podcasts

Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice?

Event: Heart Failure 2024

Topic: Anaemia/Iron Deficiency

Session type: Satellite Symposium

Late-breaking science on risk in special populations

Event: ESC Congress 2023

Topic: Cardiovascular Disease in Special Populations

Session type: Late-Breaking Science

IV iron: the story so far

Event: Heart Failure 2023

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Late-Breaking Trials - Pharmacological treatment I

Event: Heart Failure 2022

Topic: Chronic Heart Failure

Session type: Late-Breaking Science

Late Breaking Science in Artificial Intelligence & Digital Health

Event: ESC Congress 2021 - The Digital Experience

Topic: e-Cardiology/Digital Health

Session type: Late-Breaking Science

Heart failure with recovered ejection fraction, an increasingly encountered phenotype

Event: Heart Failure 2021

Topic: Chronic Heart Failure

Session type: Symposium

Iron deficiency and heart failure - evidence is piling up - what's next?

Event: Heart Failure 2021

Topic: Treatment

Session type: Satellite Symposium

All I Should Know about Heart Failure with Preserved Ejection Fraction

Event: ESC Asia with APSC & AFC

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session type: Symposium

New directions in the management of thrombotic risks in patients with heart failure

Event: ESC Congress 2018

Topic: Chronic Heart Failure

Session type: Satellite Symposium

Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors?

Event: Heart Failure 2018

Topic: Comorbidities

Session type: Satellite Symposium

ESC 365 is supported by